BioSpace News Archive

Business

Recent Job Cuts in the Biopharma Industry

BioSpace scanned the WARN (Worker Adjustment and Retraining Notification) notices across the country and compiled a small list of recent layoffs across the industry.

October 7, 2019
·
3 min read
·
Alex Keown
Career Advice

Benefits of a Targeted Job Search and How to Get Started

The more you funnel the universe of employers into a laser-focused, precise, narrow segment of those who would love to hire you, the more successful you’ll be.

October 7, 2019
·
4 min read
·
Katharine Hansen, PhD
BioCapital

ReveraGen’s Anti-Inflammatory Demonstrates Positive Results in Duchenne Muscular Dystrophy

The company presented topline data from an 18-month treatment of DMD patients with vamorolone, a first-in-class steroidal anti-inflammatory.

October 7, 2019
·
3 min read
·
Mark Terry
New evolution-busting drug overcomes resistance in aggressive breast cancers

A new type of drug that blocks one of cancer’s key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown.

October 7, 2019
·
6 min read
Promore Pharma Rights issue – correction of date

Promore Pharma AB published on 4 October 2019 the timetable for the rights issue of shares in a press release, where the record date was incorrectly stated in the text.

October 7, 2019
·
1 min read
Business

Lilian Chow joins Cerecin as Vice President of Clinical Operations and Regulatory Affairs

Cerecin continues to strengthen its experienced team in Asia Pacific as it accelerates clinical development plans

October 7, 2019
·
3 min read
Policy

Attorneys Representing Elizabeth Holmes Claim the Theranos Founder Hasn’t Paid Them in a Year

On Friday, Holmes’ attorneys from the firm Cooley LLP, who are representing her in a civil lawsuit brought against Theranos and Walgreens, filed a motion with the courts to withdraw from the case over Holmes’ failure to pay them for their work.

October 7, 2019
·
3 min read
·
Alex Keown
New Class of Drugs Could Help Treat Resistant Cancers

The drug is called BOS172722 and it forces cancer cells to multiply faster, which would seem to be counterintuitive. However, this faster cell division causes more fatal errors in the cells.

October 7, 2019
·
2 min read
·
Mark Terry
Business

Trio Wins Nobel Prize For Understanding How Cells Use Oxygen

Their work has helped in the development of new medications to fight anemia, cancer and many other diseases.

October 7, 2019
·
3 min read
·
Alex Keown
Policy

Democratic Candidate Buttigieg Calls for Stiff Penalties on Drug Companies that Do Not Negotiate Drug Prices

The proposal, which is similar to a prescription drug plan put forth by House Speaker Nancy Pelosi last month, also aims to boost new federal investments in drug development and manufacturing.

October 7, 2019
·
3 min read
·
Alex Keown